Aligos Therapeutics (ALGS) FCF Margin (2019 - 2026)
Aligos Therapeutics' FCF Margin was -817.24% in Q1 2026, up 5905.91 percentage points from -6723.15% a year earlier and up 12049.62 percentage points from the prior quarter.
Aligos Therapeutics (ALGS) FCF Margin (2019 - 2026) Analysis & Trends
For FY2025, FCF Margin at Aligos Therapeutics came in at -3774.15%, down 1534.52 percentage points from FY2024.
- FCF Margin has now declined for three consecutive years, with a four-year change of -1100.28 percentage points (FY2021 to FY2025).
- In earlier years, FCF Margin was -2239.63% in FY2024 (-1393.45 pp), -846.18% in FY2023 (-268.54 pp), -577.64% in FY2022 (+2096.23 pp) and -2673.87% in FY2021.
- The Q1 2026 figure marks the highest quarterly FCF Margin since Q2 2023.
- Compared with a year earlier, FCF Margin was higher in two of the last eight quarters, with an average year-over-year change of -1613.70 percentage points.
- The best year-over-year quarter for FCF Margin over five years was Q4 2022 (a gain of 9827.02 percentage points); the worst was Q4 2025 (a drop of 9830.07 percentage points).
- Per Business Quant data, ALGS's FCF Margin in the three quarters before Q1 2026 was -12866.86% (Q4 2025), -3285.43% (Q3 2025) and -1606.63% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.01% |
| 10 | Aligos Therapeutics | 52.83 Mn | -275.57 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -817.24% |
| Dec 31, 2025 | -12,866.86% |
| Sep 30, 2025 | -3,285.43% |
| Jun 30, 2025 | -1,606.63% |
| Mar 31, 2025 | -6,723.15% |
| Dec 31, 2024 | -3,036.80% |
| Sep 30, 2024 | -1,608.08% |
| Jun 30, 2024 | -1,837.23% |
| Mar 31, 2024 | -3,277.52% |
| Dec 31, 2023 | -1,127.82% |
| Sep 30, 2023 | -944.10% |
| Jun 30, 2023 | -317.09% |
| Mar 31, 2023 | -866.98% |
| Dec 31, 2022 | -477.07% |
| Sep 30, 2022 | -417.44% |
| Jun 30, 2022 | -686.95% |
| Mar 31, 2022 | -814.82% |
| Dec 31, 2021 | -10,304.09% |
| Sep 30, 2021 | -1,656.80% |
| Jun 30, 2021 | -1,499.68% |
Aligos Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();